These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Childhood opsoclonus-myoclonus syndrome: A case series from Tunisia. Ben Achour N; Mrabet S; Rebai I; Abid I; Benrhouma H; Klaa H; Rouissi A; Kraoua I; Ben Youssef Turki I Brain Dev; 2017 Oct; 39(9):751-755. PubMed ID: 28549713 [TBL] [Abstract][Full Text] [Related]
10. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Anderson NE; Budde-Steffen C; Rosenblum MK; Graus F; Ford D; Synek BJ; Posner JB Medicine (Baltimore); 1988 Mar; 67(2):100-9. PubMed ID: 3352511 [TBL] [Abstract][Full Text] [Related]
11. A Case of Paraneoplastic Neurological Syndrome Leading to the Diagnosis of Large Cell Neuroendocrine Carcinoma From Opsoclonus-Myoclonus Syndrome. Saito T; Maeda A; Nagano H; Kishaba T Cureus; 2023 Nov; 15(11):e48911. PubMed ID: 38106804 [TBL] [Abstract][Full Text] [Related]
12. Opsoclonus-myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma. a case report and review of the literature. De Luca S; Terrone C; Crivellaro S; De Zan A; Polo P; Vigliani MC; Tizzani A Urol Int; 2002; 68(3):206-8. PubMed ID: 11919472 [TBL] [Abstract][Full Text] [Related]
13. Anti-Ri-associated paraneoplastic ophthalmoplegia-ataxia syndrome in a woman with breast cancer: a case report and review of the literature. Sena G; Gallo G; Vescio G; Gambardella D; de Franciscis S; Renne M J Med Case Rep; 2020 Jun; 14(1):67. PubMed ID: 32527295 [TBL] [Abstract][Full Text] [Related]
14. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307 [TBL] [Abstract][Full Text] [Related]
15. Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade. Olmez OF; Kinikoglu O; Yilmaz NH; Bilici A; Cubukcu E; Seker M; Cakir T; Yildiz O; Hamdard J J Oncol Pharm Pract; 2019 Sep; 25(6):1526-1530. PubMed ID: 30124121 [TBL] [Abstract][Full Text] [Related]
16. Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer. Fonseca E; Varas R; Godoy-Santín J; Valenzuela R; Sandoval P J Neuroimmunol; 2021 Jun; 355():577570. PubMed ID: 33862421 [TBL] [Abstract][Full Text] [Related]
19. [Adult-onset opsoclonus-myoclonus-ataxia syndrome revealing rubella meningoencephalitis]. Nasri A; Mansour M; Messelmani M; Riahi A; Derbali H; Bedoui I; Zaouali J; Mrissa R Rev Med Interne; 2016 Dec; 37(12):840-843. PubMed ID: 27036225 [TBL] [Abstract][Full Text] [Related]
20. Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan. Ishaq H; Durrani T; Umar Z; Khan N; McCombe P; Ul Haq MA Front Neurol; 2021; 12():672524. PubMed ID: 34163427 [No Abstract] [Full Text] [Related] [Next] [New Search]